MedTrace Logo

A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers

NCT00991783 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2009-11-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effect of fimasartan on pharmacokinetics, and the safety of digoxin.

Conditions

  • Essential Hypertension

Interventions

DRUG

Digoxin + Fimasartan

Digoxin (7 days), Digoxin + Fimasartan (7 days)

Sponsors & Collaborators

  • Boryung Pharmaceutical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Kyung-Sang Yu, MD · Seoul National University Hospital

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2009-11-30
Completion
2009-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00991783 on ClinicalTrials.gov